Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

11 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

Radium-223 Dichloride (Alpharadin) DRKS00006460 NCT01618370 in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases (Prior Therapy) - Radium 223 Dichloride (Alpharadin) - Prior Anti-Cancer Therapy

- 13/02/2017 - 1 Formulaire, 1 Groupe Item, 7 Eléments de données, 1 Langue
Groupe Item: Prior systemic Anti-Cancer Therapy
This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product. NCT01618370

Protocol IIIA AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IIIA AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulaire, 4 Groupes Item, 32 Eléments de données, 1 Langue
Groupes Item: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IIIA. Clinical Trial Number: NCT01117441.

Protocol IIB-ASP+ AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IIB-ASP+ AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulaire, 5 Groupes Item, 28 Eléments de données, 1 Langue
Groupes Item: Patient Information, Chemotherapy Regimen, PEG-L-ASP discontinuation, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IIB (Study Protocol IIB with PEG-L-ASP). Clinical Trial Number: NCT01117441.

Protocol IB-ASP+ AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IB-ASP+ AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulaire, 5 Groupes Item, 33 Eléments de données, 1 Langue
Groupes Item: Patient Information, Chemotherapy Regimen, PEG-L-ASP discontinuation, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB (Study Protocol IB with PEG-L-ASP). Clinical Trial Number: NCT01117441.

Protocol IB AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IB AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulaire, 4 Groupes Item, 21 Eléments de données, 1 Langue
Groupes Item: Patient Information, Chemotherapy Regimen, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB. Clinical Trial Number: NCT01117441.

Protocol IIA AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IIA AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulaire, 5 Groupes Item, 31 Eléments de données, 1 Langue
Groupes Item: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IIA. Clinical Trial Number: NCT01117441.

Protocol IB AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IB AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulaire, 4 Groupes Item, 21 Eléments de données, 1 Langue
Groupes Item: Patient Information, Chemotherapy Regimen, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB. Clinical Trial Number: NCT01117441.

Protocol IB-ASP+ AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IB-ASP+ AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulaire, 5 Groupes Item, 28 Eléments de données, 1 Langue
Groupes Item: Patient Information, Chemotherapy Regimen, PEG-L-ASP discontinuation, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB (Study Protocol IB with PEG-L-ASP). Clinical Trial Number: NCT01117441.

Protocol IA-CPM AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IA-CPM AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulaire, 4 Groupes Item, 33 Eléments de données, 1 Langue
Groupes Item: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IA-CPM (Study Protocol IA with additional Cyclophosphamid). Clinical Trial Number: NCT01117441.

Protocol IA AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IA AIEOP-BFM ALL 2009 NCT01117441

- 21/05/2016 - 1 Formulaire, 5 Groupes Item, 31 Eléments de données, 1 Langue
Groupes Item: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Hospitalization, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IA (Study Protocol IA: 4 doses of Daunorubicin, Study Protocol IA': 2 doses of Daunorubicin). Clinical Trial Number: NCT01117441.

Protocol IAD AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441 - Protocol IAD AIEOP-BFM ALL 2009 NCT01117441

- 15/05/2016 - 1 Formulaire, 4 Groupes Item, 33 Eléments de données, 1 Langue
Groupes Item: Patient Information, Chemotherapy Regimen, PEG-L-ASP/ Erwinase, Identification and Signature
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IAD (Study Protocol IA with Dexamethasone). Clinical Trial Number: NCT01117441.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial